دورية أكاديمية

Early Phase I Study of a 99mTc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer.

التفاصيل البيبلوغرافية
العنوان: Early Phase I Study of a 99mTc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer.
المؤلفون: Yan Xing, Chand, Gitasha, Changchun Liu, Cook, Gary J. R., O'Doherty, Jim, Lingzhou Zhao, Wong, Nicholas C. L., Meszaros, Levente K., Hong Hoi Ting, Jinhua Zhao
المصدر: Journal of Nuclear Medicine; Sep2019, Vol. 60 Issue 9, p1213-1220, 8p, 4 Black and White Photographs, 2 Charts, 1 Graph
قاعدة البيانات: Complementary Index
الوصف
تدمد:01615505
DOI:10.2967/jnumed.118.224170